Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356462/
https://www.ncbi.nlm.nih.gov/pubmed/37476733
http://dx.doi.org/10.1155/2023/9837208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356462/
https://www.ncbi.nlm.nih.gov/pubmed/37476733
http://dx.doi.org/10.1155/2023/9837208

Ejemplares similares